Viking Therapeutics
VKTX
#2507
Rank
S$7.74 B
Marketcap
$69.47
Share price
0.19%
Change (1 day)
357.54%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -S$0.14 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.12 Billion a decrease over its 2022 earnings that were of -S$92.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.14 Billion13.8%
2023 -S$0.12 Billion24.73%
2022 -S$92.67 Million25.24%
2021 -S$74 Million39.23%
2020 -S$53.15 Million53.21%
2019 -S$34.69 Million16.84%
2018 -S$29.69 Million7.22%
2017 -S$27.69 Million39.68%
2016 -S$19.83 Million-37.05%
2015 -S$31.5 Million6.94%
2014 -S$29.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.06 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.86 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA